KIMELMAN MICHAEL 4
4 · IGENE BIOTECHNOLOGY INC · Filed Jul 23, 2009
Insider Transaction Report
Form 4
KIMELMAN MICHAEL
DirectorChairman of the Board
Transactions
- Exercise/Conversion
Common Stock
2009-07-16$0.01/sh+9,986,904$59,921→ 141,055,918 total - Conversion
Stock Options
2009-07-16$0.01/sh−14,000,000$84,000→ 0 totalExercise: $0.01From: 2009-07-16Exp: 2009-07-16→ Common Stock (9,986,904 underlying) - Conversion
Warrants
2009-07-16$0.01/sh−11,000,000$66,000→ 0 totalExercise: $0.01From: 2009-07-16Exp: 2009-07-16→ Common Stock (10,100,066 underlying) - Exercise/Conversion
Common Stock
2009-07-16$0.01/sh+10,100,066$60,600→ 131,069,014 total
Footnotes (1)
- [F1]Pursuant to Company's Board of Director's Directive dated June 16, 2009 to repurchase Options and Warrants, the Company purchased 14,000,000 stock options and 11,000,000 warrants converting them into a total of 20,086,970 shares of Common Stock.